from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2990c/-

LFCtreatmentdescriptionclass of inhibitor

0.632

Amikacinug/mL Amikacintranslation

0.723

Cap5-10ug/mL Capreomycintranslation

0.511

Rox10-50 ug/mL Roxithromycintranslation

1.880

SM2-5 ug/mL Streptomycintranslation

1.606

Tet5-10 ug/mL Tetracyclinetranslation

-0.067

Rif0.2-5ug/mL Rifampicintranscription

-0.372

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.848

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.422

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.241

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.000

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.261

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.159

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.431

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.309

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.644

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

-1.432

NaN30.2-2 mM Sodium aziderespiration

0.691

Nigericin50 uM Nigericinrespiration

-0.392

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.000

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

-0.039

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.084

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.533

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.000

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

-0.478

Amp0.2mg/mL AmpicillincellWall

-0.160

Cephalexin20-100 ug/mL CephalexincellWall

0.275

Cerulenin0.32-5 ug/mL CerulenincellWall

0.039

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.266

EMB10-20 ug/mL EthambutolcellWall

-0.581

Eta12-40 ug/mL EthionamidecellWall

-0.078

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.313

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.520

BZA0.12 mg/mL BenzamidearomaticAmides

-0.010

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.631

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.055

H2O24 mM hydrogen peroxideDNAdamaging

0.398

Levo10 ug/mL LevofloxacinDNAdamaging

-0.164

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.411

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.053

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.446

Antimycin12.5-50 ug/mL Antimycin A?

0.000

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.406

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.594

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.000

PA8240.2-2 ug/mL PA-824?

-2.413

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.183

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

1.311

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?